Spero Therapeutics, Inc. (SPRO)

NASDAQ: SPRO · Real-Time Price · USD

1.120

+0.010 (0.90%)

At close: Sep 17, 2026, 4:00 PM EDT

1.130

+0.010 (0.89%)

After-hours: Sep 17, 2026, 7:49 PM EDT

Spero Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	47	66.8	47.98	103.78	53.51	18.26
Revenue Growth	-3.25%	39.24%	-53.77%	93.95%	193.10%	95.67%
Cost of Revenue	20.53	38.47	96.76	51.44	47.59	64.53
Gross Profit	26.47	28.34	-48.78	52.34	5.92	-46.27
Selling, General & Admin	19.85	21.18	23.7	25.55	36.48	41.7
Operating Expenses	19.85	21.18	23.7	25.55	36.48	41.7
Operating Income	6.61	7.16	-72.48	26.79	-30.57	-87.97
Interest Expense	-	-	-	-	-2.61	-1.94
Interest & Investment Income	1.62	2.51	4.74	3.94	1.11	0.35
Other Non Operating Income (Expenses)	-0	0.01	0.06	-0.01	0.86	-0.19
EBT Excluding Unusual Items	8.23	9.68	-67.69	30.71	-31.2	-89.76
Merger & Restructuring Charges	-	-0.26	-0.88	-	-11.63	-
Asset Writedown	-0.59	-0.59	-	-5.31	-	-
Other Unusual Items	-	-	-	-	-3.58	-
Pretax Income	7.64	8.83	-68.57	25.4	-46.42	-89.76
Income Tax Expense	0.26	0.26	-	2.6	-	-
Earnings From Continuing Operations	7.38	8.57	-68.57	22.81	-46.42	-89.76
Net Income	7.38	8.57	-68.57	22.81	-46.42	-89.76
Net Income to Common	7.38	8.57	-68.57	22.81	-46.42	-89.76
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	57	56	54	53	38	31
Shares Outstanding (Diluted)	60	59	54	53	38	31
Shares Change	9.05%	9.25%	1.98%	40.98%	21.65%	38.01%
EPS (Basic)	0.13	0.15	-1.27	0.43	-1.23	-2.91
EPS (Diluted)	0.13	0.15	-1.27	0.43	-1.23	-2.91
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	19.58	-12.62	-23.44	-33	-7.73	-64.35
Free Cash Flow Per Share	0.33	-0.21	-0.43	-0.62	-0.21	-2.08
Gross Margin	56.31%	42.42%	-101.67%	50.43%	11.06%	-253.45%
Operating Margin	14.07%	10.72%	-151.08%	25.81%	-57.13%	-481.87%
Profit Margin	15.71%	12.83%	-142.91%	21.98%	-86.74%	-491.65%
Free Cash Flow Margin	41.66%	-18.90%	-48.86%	-31.79%	-14.45%	-352.47%
EBITDA	-	7.16	-72.48	27.15	-29.7	-87.33
EBITDA Margin	-	10.72%	-151.08%	26.16%	-55.50%	-
D&A For EBITDA	-	0	0	0.37	0.87	0.65
EBIT	6.61	7.16	-72.48	26.79	-30.57	-87.97
EBIT Margin	14.07%	10.72%	-151.08%	25.81%	-57.13%	-
Effective Tax Rate	3.41%	2.96%	-	10.23%	-	-
Revenue as Reported	47	66.8	47.98	103.78	53.51	18.26

SEC Filings: 10-K · 10-Q